100 related articles for article (PubMed ID: 8439663)
1. Protective effect of a cephalosporin, Shiomarin, plus a new potent protease inhibitor, E3123, on rat taurocholate-induced pancreatitis.
Hirano T; Manabe T; Imanishi K; Tobe T
J Gastroenterol Hepatol; 1993; 8(1):52-9. PubMed ID: 8439663
[TBL] [Abstract][Full Text] [Related]
2. Combined therapy of a cephalosporin, Shiomarin and a new potent protease inhibitor, E3123 in rat taurocholate-induced pancreatitis.
Hirano T; Manabe T
Nihon Geka Hokan; 1992 Nov; 61(6):423-32. PubMed ID: 1306980
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of prophylaxis with a protease inhibitor and a free radical scavenger against a temporary ischemia model of pancreatitis.
Hirano T; Furuyama H; Kawakami Y; Ando K; Tsuchitani T
Can J Surg; 1995 Jun; 38(3):241-8. PubMed ID: 7540502
[TBL] [Abstract][Full Text] [Related]
4. Effect of short-termed pancreatico-biliary duct obstruction on lysosomal enzyme in rats: protective effect of a potent new protease inhibitor, E-3123.
Hirano T; Manabe T; Yotsumoto F; Ohshio G; Nio Y
Nihon Geka Hokan; 1992 May; 61(3):234-48. PubMed ID: 1280076
[TBL] [Abstract][Full Text] [Related]
5. Intracellular action of an exogenous low-molecular-weight synthetic protease inhibitor, E3123, in cerulein-induced acute pancreatitis in rats.
Sata N; Atomi Y; Kimura W; Kuroda A; Muto T; Mineo C
Int J Pancreatol; 1994 Apr; 15(2):119-27. PubMed ID: 8071570
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of combined therapy with a protease inhibitor, ONO 3307, and a xanthine oxidase inhibitor, allopurinol on temporary ischaemic model of pancreatitis in rats.
Hirano T; Manabe T; Ohshio G; Nio Y
Nihon Geka Hokan; 1992 May; 61(3):224-33. PubMed ID: 1444702
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of therapy with a protease and xanthine oxidase inhibitor in short form pancreatic biliary obstruction and ischemia in rats.
Hirano T; Manabe T; Steer M; Printz H; Calne R; Tobe T
Surg Gynecol Obstet; 1993 Apr; 176(4):371-81. PubMed ID: 8460415
[TBL] [Abstract][Full Text] [Related]
8. Improved survival in mice with diet-induced pancreatitis treated with new potent protease inhibitor, E-3123 and a broad spectrum antibiotic, cefmetazole.
Hirano T; Manabe T; Ohshio G; Nio Y
Nihon Geka Hokan; 1992 May; 61(3):213-23. PubMed ID: 1444701
[TBL] [Abstract][Full Text] [Related]
9. Cytoprotective effects of prostaglandins and a new potent protease inhibitor in acute pancreatitis.
Hirano T; Manabe T; Tobe T
Am J Med Sci; 1992 Sep; 304(3):154-63. PubMed ID: 1282294
[TBL] [Abstract][Full Text] [Related]
10. Acute cytotoxic effect of cyclosporin A on pancreatic acinar cells in rats. Protective effect of the synthetic protease inhibitor E3123.
Hirano T; Manabe T; Ando K; Tobe T
Scand J Gastroenterol; 1992; 27(2):103-7. PubMed ID: 1373246
[TBL] [Abstract][Full Text] [Related]
11. Protection by a new synthetic protease inhibitor, ONO3307, of the rat exocrine pancreas during acute edematous pancreatitis induced by a supramaximal dose of caerulein in comparison with FOY007.
Hirano T; Manabe T; Tobe T
Pharmacology; 1992; 45(2):107-16. PubMed ID: 1381836
[TBL] [Abstract][Full Text] [Related]
12. A new synthetic protease inhibitor, E-3123, prevents lysosomal and mitochondrial fragility in rat caerulein-induced pancreatitis.
Hirano T; Manabe T
J Int Med Res; 1992 Jun; 20(3):211-7. PubMed ID: 1383065
[TBL] [Abstract][Full Text] [Related]
13. Monitoring serum tryptic activity and effect of trypsin inhibitor on rat acute pancreatitis.
Sobajima H; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Ishiguro H; Tanikawa M; Nakae Y
Digestion; 1994; 55(2):90-6. PubMed ID: 7514553
[TBL] [Abstract][Full Text] [Related]
14. [Changes of acinar cells in the pancreato-biliary duct ligation with exocrine pancreatic stimulation model in rats; protective effects of a new potent protease inhibitor, ONO3307].
Hirano T; Yotsumoto TM; Ando K; Tobe T
Nihon Geka Hokan; 1991 Sep; 60(5):342-53. PubMed ID: 1726453
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of the combined treatment of pancreatic and neutrophil elastase inhibitors on acute pancreatitis elicited by lipopolysaccharide in rats given intraductal injection of taurocholate plus trypsin.
Yamano M; Umeda M; Miyata K; Yamada T
Naunyn Schmiedebergs Arch Pharmacol; 1998 May; 357(5):558-64. PubMed ID: 9650810
[TBL] [Abstract][Full Text] [Related]
16. [Effects of E3123 on pancreatic injury in the isolated, perfused rat pancreas and in a pancreatic slice].
Miyamoto K; Nagakawa J; Nagaoka N; Hishinuma I; Nagaoka J; Yamanaka T; Wakabayashi T
Nihon Yakurigaku Zasshi; 1994 Oct; 104(4):337-45. PubMed ID: 7959424
[TBL] [Abstract][Full Text] [Related]
17. [The cellular and lysosomal fragility of pancreatic acinar cells after ligation of pancreatico-biliary duct in the rat and the protective effects of nafamostat mesilate].
Hirano T; Manabe T; Tobe T
Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1489-500. PubMed ID: 1283776
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute pancreatitis on hepatic secretion of lysosomal enzymes into bile and hepatic lysosomal fragility: protective effects of a new synthetic protease inhibitor, ONO 3307.
Hirano T; Manabe T; Calne R; Tobe T
Scand J Gastroenterol; 1992; 27(3):227-32. PubMed ID: 1502486
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of a pancreatic elastase inhibitor against a variety of acute pancreatitis in rats.
Yamano M; Miyata K; Yamada T
Jpn J Pharmacol; 1998 Jul; 77(3):193-203. PubMed ID: 9717766
[TBL] [Abstract][Full Text] [Related]
20. Effect of FOY-305 (camostate) on severe acute pancreatitis in two experimental animal models.
Lankisch PG; Pohl U; Göke B; Otto J; Wereszczynska-Siemiatkowska U; Gröne HJ; Rahlf G
Gastroenterology; 1989 Jan; 96(1):193-9. PubMed ID: 2909420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
